Complex ankle arthrodesis using the ilizarov method yields high rate of fusion foot and ankle

Austin T. Fragomen, Eugene Borst, Lindsay Schachter, Leonard Lyman Stephen, S. Robert Rozbruch

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Ankle arthrodesis may be achieved using the Ilizarov method. Comorbidities, such as diabetes, Charcot neuroarthropathy, osteomyelitis, leg length discrepancy, and smoking, can make an ankle fusion complex and may be associated with lower rates of healing. Questions/Purposes: We asked if (1) smoking and other comorbidities led to lower fusion rates, (2) time wearing the frame affected outcome, and (3) simultaneous tibial lengthening improved fusion rates. Methods: We retrospectively studied 101 patients who underwent complex ankle fusion using the Ilizarov technique. The median time wearing the frame was 25 weeks (range, 10-65 weeks). Twenty-four patients had simultaneous tibial lengthening. The minimum followup for 91 of the 101 patients was 27 months (median, 65 months; range, 27-134 months). Results: Fusion was achieved in 76 of 91 patients. Smoking was associated with a 54% rate of nonunion. Fifteen of 19 patients with Charcot neuroarthropathy achieved union but had a high rate of subsequent subtalar joint failure. Time wearing the frame did not affect union rates. Tibial lengthening did not improve ankle fusion rates. Conclusion: Smokers should be warned of the high risk of nonunion and we recommend they quit smoking. We also recommend surgeons recognize the higher nonunion rate in patients with Charcot neuroarthropathy. We believe tibial lengthening should not be performed to enhance healing at the fusion site. Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.

Original languageEnglish
Pages (from-to)2864-2873
Number of pages10
JournalClinical orthopaedics and related research
Volume470
Issue number10
DOIs
Publication statusPublished - Jan 1 2012
Externally publishedYes

Fingerprint

Ilizarov Technique
Arthrodesis
Ankle
Foot
Smoking
Comorbidity
Subtalar Joint
Osteomyelitis
Leg
Guidelines

All Science Journal Classification (ASJC) codes

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Complex ankle arthrodesis using the ilizarov method yields high rate of fusion foot and ankle. / Fragomen, Austin T.; Borst, Eugene; Schachter, Lindsay; Lyman Stephen, Leonard; Rozbruch, S. Robert.

In: Clinical orthopaedics and related research, Vol. 470, No. 10, 01.01.2012, p. 2864-2873.

Research output: Contribution to journalArticle

Fragomen, Austin T. ; Borst, Eugene ; Schachter, Lindsay ; Lyman Stephen, Leonard ; Rozbruch, S. Robert. / Complex ankle arthrodesis using the ilizarov method yields high rate of fusion foot and ankle. In: Clinical orthopaedics and related research. 2012 ; Vol. 470, No. 10. pp. 2864-2873.
@article{4ee35db8e9f64f09a79e778de3156139,
title = "Complex ankle arthrodesis using the ilizarov method yields high rate of fusion foot and ankle",
abstract = "Background: Ankle arthrodesis may be achieved using the Ilizarov method. Comorbidities, such as diabetes, Charcot neuroarthropathy, osteomyelitis, leg length discrepancy, and smoking, can make an ankle fusion complex and may be associated with lower rates of healing. Questions/Purposes: We asked if (1) smoking and other comorbidities led to lower fusion rates, (2) time wearing the frame affected outcome, and (3) simultaneous tibial lengthening improved fusion rates. Methods: We retrospectively studied 101 patients who underwent complex ankle fusion using the Ilizarov technique. The median time wearing the frame was 25 weeks (range, 10-65 weeks). Twenty-four patients had simultaneous tibial lengthening. The minimum followup for 91 of the 101 patients was 27 months (median, 65 months; range, 27-134 months). Results: Fusion was achieved in 76 of 91 patients. Smoking was associated with a 54{\%} rate of nonunion. Fifteen of 19 patients with Charcot neuroarthropathy achieved union but had a high rate of subsequent subtalar joint failure. Time wearing the frame did not affect union rates. Tibial lengthening did not improve ankle fusion rates. Conclusion: Smokers should be warned of the high risk of nonunion and we recommend they quit smoking. We also recommend surgeons recognize the higher nonunion rate in patients with Charcot neuroarthropathy. We believe tibial lengthening should not be performed to enhance healing at the fusion site. Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.",
author = "Fragomen, {Austin T.} and Eugene Borst and Lindsay Schachter and {Lyman Stephen}, Leonard and Rozbruch, {S. Robert}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/s11999-012-2470-9",
language = "English",
volume = "470",
pages = "2864--2873",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Complex ankle arthrodesis using the ilizarov method yields high rate of fusion foot and ankle

AU - Fragomen, Austin T.

AU - Borst, Eugene

AU - Schachter, Lindsay

AU - Lyman Stephen, Leonard

AU - Rozbruch, S. Robert

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background: Ankle arthrodesis may be achieved using the Ilizarov method. Comorbidities, such as diabetes, Charcot neuroarthropathy, osteomyelitis, leg length discrepancy, and smoking, can make an ankle fusion complex and may be associated with lower rates of healing. Questions/Purposes: We asked if (1) smoking and other comorbidities led to lower fusion rates, (2) time wearing the frame affected outcome, and (3) simultaneous tibial lengthening improved fusion rates. Methods: We retrospectively studied 101 patients who underwent complex ankle fusion using the Ilizarov technique. The median time wearing the frame was 25 weeks (range, 10-65 weeks). Twenty-four patients had simultaneous tibial lengthening. The minimum followup for 91 of the 101 patients was 27 months (median, 65 months; range, 27-134 months). Results: Fusion was achieved in 76 of 91 patients. Smoking was associated with a 54% rate of nonunion. Fifteen of 19 patients with Charcot neuroarthropathy achieved union but had a high rate of subsequent subtalar joint failure. Time wearing the frame did not affect union rates. Tibial lengthening did not improve ankle fusion rates. Conclusion: Smokers should be warned of the high risk of nonunion and we recommend they quit smoking. We also recommend surgeons recognize the higher nonunion rate in patients with Charcot neuroarthropathy. We believe tibial lengthening should not be performed to enhance healing at the fusion site. Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.

AB - Background: Ankle arthrodesis may be achieved using the Ilizarov method. Comorbidities, such as diabetes, Charcot neuroarthropathy, osteomyelitis, leg length discrepancy, and smoking, can make an ankle fusion complex and may be associated with lower rates of healing. Questions/Purposes: We asked if (1) smoking and other comorbidities led to lower fusion rates, (2) time wearing the frame affected outcome, and (3) simultaneous tibial lengthening improved fusion rates. Methods: We retrospectively studied 101 patients who underwent complex ankle fusion using the Ilizarov technique. The median time wearing the frame was 25 weeks (range, 10-65 weeks). Twenty-four patients had simultaneous tibial lengthening. The minimum followup for 91 of the 101 patients was 27 months (median, 65 months; range, 27-134 months). Results: Fusion was achieved in 76 of 91 patients. Smoking was associated with a 54% rate of nonunion. Fifteen of 19 patients with Charcot neuroarthropathy achieved union but had a high rate of subsequent subtalar joint failure. Time wearing the frame did not affect union rates. Tibial lengthening did not improve ankle fusion rates. Conclusion: Smokers should be warned of the high risk of nonunion and we recommend they quit smoking. We also recommend surgeons recognize the higher nonunion rate in patients with Charcot neuroarthropathy. We believe tibial lengthening should not be performed to enhance healing at the fusion site. Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.

UR - http://www.scopus.com/inward/record.url?scp=84866363306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866363306&partnerID=8YFLogxK

U2 - 10.1007/s11999-012-2470-9

DO - 10.1007/s11999-012-2470-9

M3 - Article

C2 - 22777590

AN - SCOPUS:84866363306

VL - 470

SP - 2864

EP - 2873

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 10

ER -